FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teligent Pharma Lidocaine Hydrochloride Topical Solution 4% Recall

Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Onl…

Teligent Pharma, Inc. · Buena, NJ

Risk level
Class II
Reported by FDA
Dec 22, 2021
Recall ID
D-0281-2022
Check your lot numberHow we source this data

Summary

Teligent Pharma recalled Lidocaine Hydrochloride Topical Solution 4% starting Oct 12, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0281-2022 on Dec 22, 2021. Reason: CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent. Status: Terminated.

Why it was recalled

CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.

Product description

Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50

Lot numbers, UPCs & expiration codes

Lot #: 13058, Exp. date 02/2022 and 13768, Exp. date 05/2022

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0281-2022
Classification
Class II
Status
Terminated
Recall initiated
Oct 12, 2021
FDA report date
Dec 22, 2021
Quantity
14,664 glass bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Teligent Pharma, Inc.

Original FDA data

Every field from FDA enforcement report D-0281-2022, exactly as published.

Show all FDA fields
City
Buena
State
NJ
Status
Terminated
Country
United States
Event ID
88850
Address
105 Lincoln Avenue
Code information
Lot #: 13058, Exp. date 02/2022 and 13768, Exp. date 05/2022
Postal code
08310
Report date
Dec 22, 2021
Product type
Drugs
Recall number
D-0281-2022
Classification
Class II
Recalling firm
Teligent Pharma, Inc.
Product quantity
14,664 glass bottles
Termination date
Jun 18, 2024
Reason for recall
CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50
Distribution pattern
Nationwide within the United States
Recall initiation date
Oct 12, 2021
Initial firm notification
Press Release
Center classification date
Dec 13, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0281-2022, published Dec 22, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls